| 23016952 | 14-Alkoxy- and 14-acyloxypyridomorphinans: μ agonist/δ antagonist opioid analgesics with diminished tolerance and dependence side effects. | J Med Chem | 2012 |
| 19953652 | Identification of a novel "almost neutral" micro-opioid receptor antagonist in CHO cells expressing the cloned human mu-opioid receptor. | Synapse | 2010 |
| 21039196 | Magnetic resonance lymphangiography with a nano-sized gadolinium-labeled dendrimer in small and large animal models. | Nanomedicine (Lond) | 2010 |
| 21036244 | In vitro and in vivo assessment of mu opioid receptor constitutive activity. | Methods Enzymol | 2010 |
| 19505829 | Toward preparation of antibody-based imaging probe libraries for dual-modality positron emission tomography and fluorescence imaging. | Bioorg Med Chem | 2009 |
| 19423001 | Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH. | Nucl Med Biol | 2009 |
| 19555072 | A new approach in the preparation of dendrimer-based bifunctional diethylenetriaminepentaacetic acid MR contrast agent derivatives. | Bioconjug Chem | 2009 |
| 18359632 | A novel bifunctional maleimido CHX-A'' chelator for conjugation to thiol-containing biomolecules. | Bioorg Med Chem Lett | 2008 |
| 18472184 | Evidence for a mu-delta opioid receptor complex in CHO cells co-expressing mu and delta opioid peptide receptors. | Peptides | 2008 |
| 18639745 | Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptors. | Brain Res Bull | 2008 |
| 18597510 | Synthesis of a cross-bridged cyclam derivative for peptide conjugation and 64Cu radiolabeling. | Bioconjug Chem | 2008 |
| 18620447 | Evaluation of a maleimido derivative of CHX-A'' DTPA for site-specific labeling of affibody molecules. | Bioconjug Chem | 2008 |
| 17152090 | A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) mu-opioid agonists on cellular markers related to opioid tolerance and dependence. | Synapse | 2007 |
| 17552504 | Toward improved syntheses of dendrimer-based magnetic resonance imaging contrast agents: new bifunctional diethylenetriaminepentaacetic acid ligands and nonaqueous conjugation chemistry. | J Med Chem | 2007 |
| 17711320 | Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging. | Bioconjug Chem | 2007 |
| 17725340 | Design, synthesis, and characterization of a dual modality positron emission tomography and fluorescence imaging agent for monoclonal antibody tumor-targeted imaging. | J Med Chem | 2007 |
| 17060492 | Salvinorin A: allosteric interactions at the mu-opioid receptor. | J Pharmacol Exp Ther | 2007 |
| 16165252 | Regulation of the rat brain endothelin system by endogenous beta-endorphin. | Peptides | 2006 |
| 16672569 | Antinociceptive and hypothermic effects of Salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout mice. | J Pharmacol Exp Ther | 2006 |
| 15987828 | Chronic morphine up-regulates G alpha12 and cytoskeletal proteins in Chinese hamster ovary cells expressing the cloned mu opioid receptor. | J Pharmacol Exp Ther | 2005 |
| 15937150 | (+/-)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane. | J Pharmacol Exp Ther | 2005 |
| 15065220 | Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor. | Synapse | 2004 |
| 15541896 | Intracerebroventricular administration of anti-endothelin-1 IgG selectively upregulates endothelin-A and kappa opioid receptors. | Neuroscience | 2004 |
| 15266556 | 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. | Synapse | 2004 |
| 12422367 | Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor. | Synapse | 2003 |
| 12732339 | Endogenous CART peptide regulates mu opioid and serotonin 5-HT(2A) receptors. | Peptides | 2003 |
| 12825951 | Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonist. | J Med Chem | 2003 |
| 11954042 | In vitro and in vivo characterization of [125I]iodomethyllycaconitine in the rat. | Synapse | 2002 |
| 12139463 | Discovery of an opioid kappa receptor selective pure antagonist from a library of N-substituted 4beta-methyl-5-(3-hydroxyphenyl)morphans. | J Med Chem | 2002 |
| 12535696 | Endogenous corticotropin releasing factor regulates adrenergic and opioid receptors. | Peptides | 2002 |
| 11071711 | Opioid peptide receptor studies. 14. Stereochemistry determines agonist efficacy and intrinsic efficacy in the [(35)S]GTP-gamma-S functional binding assay. | Synapse | 2001 |
| 11311071 | Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2',3'-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy. | J Med Chem | 2001 |
| 11309842 | Opioid peptide receptor studies. 15. Relative efficacy of 4-[(N-allyl-3-methyl-4-piperidinyl)phenylamino]-N,N-diethylbenzamide and related compounds at the cloned human delta-opioid receptor. | Synapse | 2001 |
| 11300879 | Factors influencing agonist potency and selectivity for the opioid delta receptor are revealed in structure-activity relationship studies of the 4-[(N-substituted-4-piperidinyl)arylamino]-N,N-diethylbenzamides. | J Med Chem | 2001 |
| 11543951 | SoRI 9409, a non-peptide opioid mu receptor agonist/delta receptor antagonist, fails to stimulate [35S]-GTP-gamma-S binding at cloned opioid receptors. | Brain Res Bull | 2001 |
| 11495579 | Identification of the first trans-(3R,4R)- dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activity. | J Med Chem | 2001 |
| 11418937 | [(125)I]3beta-(4-ethyl-3-iodophenyl)nortropane-2beta-carboxylic acid methyl ester ([(125)I]EINT): a potent and selective radioligand for the brain serotonin transporter. | Synapse | 2001 |
| 10649969 | Synthesis and pharmacological characterization of [(125)I]iodomethyllycaconitine ([(125)I]iodo-MLA). A new ligand for the alpha(7) nicotinic acetylcholine receptor. | J Med Chem | 2000 |
| 10866400 | 4-[(8-Alkyl-8-azabicyclo[3.2.1]octyl-3-yl)-3-arylanilino]-N,N-diethylbenzamides: high affinity, selective ligands for the delta opioid receptor illustrate factors important to antagonist activity. | Bioorg Med Chem Lett | 2000 |
| 10956228 | Probes for narcotic receptor-mediated phenomena. 27. Synthesis and pharmacological evaluation of selective delta-opioid receptor agonists from 4-[(alphaR)-alpha-(2S,5R)-4-substituted-2, 5-dimethyl-1-piperazinyl-3-methoxybenzyl]-N,N-diethylbenzamides and their enantiomers. | J Med Chem | 2000 |
| 10479286 | Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans. | J Med Chem | 1999 |
| 10188634 | Opioid peptide receptor studies, 11: involvement of Tyr148, Trp318 and His319 of the rat mu-opioid receptor in binding of mu-selective ligands. | Synapse | 1999 |
| 10612597 | Optically pure (-)-4-[(N-allyl-3-methyl-4-piperidinyl)phenyl-amino]-N,N-diethylbenzami de displays selective binding and full agonist activity for the delta opioid receptor. | Bioorg Med Chem Lett | 1999 |
| 10571174 | (+/-)-4-[(N-allyl-cis-3-methyl-4-piperidinyl)phenylamino]-N,N-diethylbenzamide displays selective binding for the delta opioid receptor. | Bioorg Med Chem Lett | 1999 |
| 9857089 | Identification of an opioid kappa receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine. | J Med Chem | 1998 |
| 9450512 | Opioid peptide receptor studies. 7. The methylfentanyl congener RTI-4614-4 and its four enantiomers bind to different domains of the rat mu opioid receptor. | Synapse | 1998 |
| 9873693 | N-substituted octahydro-4a-(3-hydroxyphenyl)-10a-methyl-benzo[g]isoquinolines are opioid receptor pure antagonists. | Bioorg Med Chem Lett | 1998 |
| 9599247 | Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonists. | J Med Chem | 1998 |
| 9493867 | Opioid peptide receptor studies. 8. One of the mouse brain deltaNCX binding sites is similar to the cloned mouse opioid delta receptor: further evidence for heterogeneity of delta opioid receptors. | Peptides | 1998 |
| 9667975 | Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety. | J Med Chem | 1998 |